INCA034176 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-03 in 11d
ESTIMATED |
READOUT
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent
Phase 1/2 · Chronic Graft-versus-host-disease |
INCY INCYTE CORP | INCA034176 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|